An assessment of adherence to the WHO-delineated good manufacturing practice by the pharmaceutical companies in Kabul, Afghanistan.

Rohullah Roien Rajeev ShresthaKashikant YadavAkihiko OzakiM Bashir AhmadiYudai KanedaYasuhiro KoteraBinaya SapkotaSunil Shrestha

Published in: Cost effectiveness and resource allocation : C/E (2022)

None of the GMP components was fully adhered to by the pharmaceutical companies in Kabul, Afghanistan. Quality control and assurance should be implemented immediately, including validation and qualification practices.

Keyphrases

quality control
primary care
healthcare
biofilm formation
quality improvement
skeletal muscle
pseudomonas aeruginosa